Transmission trends for human immunodeficiency virus associated tuberculosis in New York City

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 6, 2005, Pages 661-666

  Geng, Elvin H ^a   Kreiswirth, B N ^b   Burzynski, J ^c   Schluger, N W ^a,d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d Department of Medicine   (United States)

Author keywords

Epidemiology; HIV; Public health; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS;

EID: 20444442735     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tuberculosis morbidity-United States, 1994. MMWR 1995; 44: 387-389, 395.
2. Brudney K, Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Semin Respir Infect 1991; 6: 261-272.
3. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 16; 330: 1703-1709.
4. Alland D, Kalkut G E, Moss A R, et al. Transmission of tuberculosis in New York City-an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.
5. Frieden T R, Fujiwara P I, Washko R M, Hamburg M A. Tuberculosis in New York City-turning the tide. N Engl J Med 1995; 333: 229-233.
6. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2003. Atlanta, GA: US Department of Health and Human Services, CDC, 2004.
7. McKenna M T, McCray E, Jones J L, Onorato I M, Castro K G. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am J Public Health 1998; 88: 1059-1063.
8. New York City Department of Health and Mental Hygiene. Tuberculosis in New York City, 2002: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene, 2003.
9. Centers for Disease Control and Prevention. Tuberculosis morbidity among U.S.-born and foreign-born populations-United States, 2000. MMWR 2002; 51: 101-104.
10. Selwyn P A, D, Hartel V A, Lewis E E, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
11. Daley C L, Small P M, Schecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-235.
12. Small P M, Shafer R W, Hopewell P C, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-1144.
13. Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001; 249: 1-26.
14. Bauer J, Andersen A B, Kremer K, Miorner H. Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol 1999; 37: 2602-2606.
15. Soini H, Pan X, Teeter L, Musser J M, Graviss E A. Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. J Clin Microbiol 2001; 39: 217-221.
16. Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999; 37: 2607-2618.
17. Sterling T R, Thompson D, Stanley R L, et al. A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination. Int J Tuberc Lung Dis 2000; 4: 1066-1073.
18. McElroy P D, Southwick K L, Fortenberry E R, et al. Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus. Clin Infect Dis 2003; 36: 1305-1312.
19. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin. MMWR 1996; 45: 921-925.
20. Narita M, Ashkin D, Hollender E S, Pitchenik A E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-161.
21. De Cock K M, Chaisson R E. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999; 3: 457-465.
22. Burgos, M, DeRiemer K, Small P M, Hopewell P C, Daley C L. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis 2003; 188: 1878-1884.
23. New York City Department of Health and Mental Hygiene. Tuberculosis in New York City, 2000: Information summary. New York, NY: New York City Department of Health and Mental Hygiene, 2001.